Cancer Stem Cell News
Cell Therapy News
Dermal Cell News
Endothelial Cell News
ESC & iPSC News
Extracellular Matrix News
Hematopoiesis News
Hepatic Cell News
Human Immunology News
Immune Regulation News
Intestinal Cell News
Mammary Cell News
Mesenchymal Cell News
Muscle Cell News
Neural Cell News
Organoid News
Pancreatic Cell News
Prostate Cell News
Pulmonary Cell NewsScientists highlight recent advance in targeted polymeric nanoformulations that are coated with varying ligands and loaded with different therapeutic agents for directing to distinct targets in hematological malignancies.
[Journal of Controlled Release]
6445212 MSQGHQXL items 1 apa 0 default asc 1 165502 https://www.stemcellsciencenews.com/wp-content/plugins/zotpress/
%7B%22status%22%3A%22success%22%2C%22updateneeded%22%3Afalse%2C%22instance%22%3A%22zotpress-4df66aaa50748c8996ba73dcdc6f340b%22%2C%22meta%22%3A%7B%22request_last%22%3A0%2C%22request_next%22%3A0%2C%22used_cache%22%3Atrue%7D%2C%22data%22%3A%5B%7B%22key%22%3A%22MSQGHQXL%22%2C%22library%22%3A%7B%22id%22%3A6445212%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Gu%20et%20al.%22%2C%22parsedDate%22%3A%222021-08-06%22%2C%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%202%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%3EGu%2C%20W.%2C%20Qu%2C%20R.%2C%20Meng%2C%20F.%2C%20Cornelissen%2C%20J.%20J.%20L.%20M.%2C%20%26amp%3B%20Zhong%2C%20Z.%20%282021%29.%20Polymeric%20nanomedicines%20targeting%20hematological%20malignancies.%20%3Ci%3EJournal%20of%20Controlled%20Release%3C%5C%2Fi%3E.%20%3Ca%20href%3D%27https%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2Fj.jconrel.2021.08.001%27%3Ehttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2Fj.jconrel.2021.08.001%3C%5C%2Fa%3E%20%3Ca%20title%3D%27Cite%20in%20RIS%20Format%27%20class%3D%27zp-CiteRIS%27%20href%3D%27https%3A%5C%2F%5C%2Fwww.stemcellsciencenews.com%5C%2Fwp-content%5C%2Fplugins%5C%2Fzotpress%5C%2Flib%5C%2Frequest%5C%2Frequest.cite.php%3Fapi_user_id%3D6445212%26amp%3Bitem_key%3DMSQGHQXL%27%3ECite%3C%5C%2Fa%3E%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Polymeric%20nanomedicines%20targeting%20hematological%20malignancies%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Wenxing%22%2C%22lastName%22%3A%22Gu%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ruobing%22%2C%22lastName%22%3A%22Qu%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Fenghua%22%2C%22lastName%22%3A%22Meng%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jeroen%20J.%20L.%20M.%22%2C%22lastName%22%3A%22Cornelissen%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Zhiyuan%22%2C%22lastName%22%3A%22Zhong%22%7D%5D%2C%22abstractNote%22%3A%22Hematological%20malignancies%20%28HMs%29%20typically%20persisting%20in%20the%20blood%2C%20lymphoma%2C%20and%5C%2For%20bone%20marrow%20invalidate%20surgery%20and%20local%20treatments%20clinically%20used%20for%20solid%20tumors.%20The%20presence%20and%20drug%20resistance%20nature%20of%20cancer%20stem%20cells%20%28CSCs%29%20further%20lends%20HMs%20hard%20to%20cure.%20The%20development%20of%20new%20treatments%20like%20molecular%20targeted%20drugs%20and%20antibodies%20has%20improved%20the%20clinical%20outcomes%20for%20HMs%20but%20only%20to%20a%20certain%20extent%2C%20due%20to%20issues%20of%20low%20bioavailability%2C%20moderate%20response%2C%20occurrence%20of%20drug%20resistance%2C%20and%5C%2For%20dose-limiting%20toxicities.%20In%20the%20past%20years%2C%20polymeric%20nanomedicines%20targeting%20HMs%20including%20refractory%20and%20relapsed%20lymphoma%2C%20leukemia%20and%20multiple%20myeloma%20have%20emerged%20as%20a%20promising%20chemotherapeutic%20approach%20that%20is%20shown%20capable%20of%20overcoming%20drug%20resistance%2C%20delivering%20drugs%20not%20only%20to%20cancer%20cells%20but%20also%20CSCs%2C%20and%20increasing%20therapeutic%20index%20by%20lessening%20drug-associated%20adverse%20effects.%20In%20addition%2C%20polymeric%20nanomedicines%20have%20shown%20to%20potentiate%20next-generation%20anticancer%20modalities%20such%20as%20therapeutic%20proteins%20and%20nucleic%20acids%20in%20effectively%20treating%20HMs.%20In%20this%20review%2C%20we%20highlight%20recent%20advance%20in%20targeted%20polymeric%20nanoformulations%20that%20are%20coated%20with%20varying%20ligands%20%28e.g.%20cancer%20cell%20membrane%20proteins%2C%20antibodies%2C%20transferrin%2C%20hyaluronic%20acid%2C%20aptamer%2C%20peptide%2C%20and%20folate%29%20and%20loaded%20with%20different%20therapeutic%20agents%20%28e.g.%20chemotherapeutics%2C%20molecular%20targeted%20drugs%2C%20therapeutic%20antibodies%2C%20nucleic%20acid%20drugs%2C%20and%20apoptotic%20proteins%29%20for%20directing%20to%20distinct%20targets%20%28e.g.%20CD19%2C%20CD20%2C%20CD22%2C%20CD30%2C%20CD38%2C%20CD44%2C%20CD64%2C%20CXCR%2C%20FLT3%2C%20VLA-4%2C%20and%20bone%20marrow%20microenvironment%29%20in%20HMs.%20The%20advantages%20and%20potential%20challenges%20of%20different%20designs%20are%20discussed.%22%2C%22date%22%3A%22August%206%2C%202021%22%2C%22language%22%3A%22en%22%2C%22DOI%22%3A%2210.1016%5C%2Fj.jconrel.2021.08.001%22%2C%22ISSN%22%3A%220168-3659%22%2C%22url%22%3A%22https%3A%5C%2F%5C%2Fwww.sciencedirect.com%5C%2Fscience%5C%2Farticle%5C%2Fpii%5C%2FS0168365921004004%22%2C%22collections%22%3A%5B%5D%2C%22dateModified%22%3A%222021-08-10T18%3A04%3A10Z%22%7D%7D%5D%7D
Gu, W., Qu, R., Meng, F., Cornelissen, J. J. L. M., & Zhong, Z. (2021). Polymeric nanomedicines targeting hematological malignancies. Journal of Controlled Release. https://doi.org/10.1016/j.jconrel.2021.08.001 Cite
